Details
- Status
- Closed
- Opening date
- Deadline
- Department
- Directorate-General for Health and Food Safety
Target audience
Public health community
Why we are consulting
Period of consultation
From 6 February 2013 to 30 April 2013.
Contributions to and results of the consultation
Gedeon Richter Plc., Merck & Co., Norgine and UCB Pharma SA requested that their responses not be published.
Below are the public responses to the above-mentioned public consultation:
- AEMPS - Agencia Española de Medicamentos y Productos Sanitario
- AESGP - Association Européenne des Spécialités Pharmaceutiques Grand Public
- EFCG - European Fine Chemicals Group
- EFPIA - European Federation of Pharmaceutical Industries
- FECC - Europen Association of Chemical Distributors
- GE Healthcare Medical Diagnostics
- GENUS PHARMACEUTICALS
- IPEC - International Pharmaceutical Excipients Council Europe
- LEEM - Les entreprises du médicaments
- LFB-Biomédicaments
- MAGYOS
- PDA - Parenteral Drug Association
- PHARMIG - Association of the Austrian pharmaceutical industries
- SANDOZ INTERNATIONAL GmbH
- SCIENCE PHARMA
The consultation document
The consultation document can be downloaded here.
Protection of personal data
The policy on "protection of individuals with regard to the processing of personal data by the Community institutions" is based on Regulation (EC) N° 45/2001 of the European Parliament and of the Council of 18 December 2000. More information is available here.